Related Experiment Video
Updated: Jul 10, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Medical therapy for obesity--current status and future hopes
1Pennington Center, 6400 Perkins Road, Baton Rouge, LA 70808, USA. brayga@pbrc.edu
Abstract:
In accepting any new drug for the treatment of obesity, the safety profile must make it acceptable for almost everyone. Criteria for selecting treatments involve evaluating the risks to the individual from obesity and balancing that against any possible problems with the treatment. Obesity is a chronic disease that has many causes. Cure is rare and treatment is thus aimed at palliation, that is, producing and maintaining weight loss. Wherever the primary site of action may be, however, the net effect must be a reduction in food intake or an increase in energy expenditure.
Insights
New obesity drugs require excellent safety profiles for widespread use. Treatment focuses on managing this chronic disease by reducing food intake or increasing energy expenditure for sustained weight loss.
Area of Science:
- Pharmacology and Therapeutics
- Metabolic Diseases
- Public Health
Background:
- Obesity is a complex, chronic disease with diverse etiologies.
- Effective treatment requires balancing individual risks of obesity against potential treatment side effects.
- Current therapeutic strategies aim for disease management rather than a cure.
Purpose of the Study:
- To outline the essential safety and efficacy criteria for novel obesity pharmacotherapies.
- To emphasize the need for treatments that support long-term weight management.
- To define the fundamental physiological outcomes required for successful obesity interventions.
Main Methods:
- Review of established principles in pharmacotherapy selection for chronic conditions.
- Analysis of risk-benefit assessments in the context of obesity management.
- Evaluation of physiological targets for weight reduction.
Main Results:
- Safety is paramount for broad patient acceptance of obesity medications.
- Treatment efficacy is measured by the ability to achieve and maintain weight loss.
- The net effect of any intervention must be reduced caloric intake or increased energy expenditure.
Conclusions:
- Novel obesity drugs must demonstrate a highly favorable safety profile.
- Successful obesity treatment necessitates a focus on sustained weight management.
- Pharmacological interventions should aim to modulate energy balance through diet or expenditure.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Obesity
Drug Therapy
Antianxiety Medications
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Atherosclerosis III: Management
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
